|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer J Int Du Cancer. 127:2893–2917.
2010. View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown PO and Palmer C: The preclinical
natural history of serous ovarian cancer: Defining the target for
early detection. PLoS Med. 6:e10001142009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Auersperg N, Wong A, Choi K, Kang S and
Leung P: Ovarian surface epithelium: Biology, endocrinology, and
pathology. Endocr Rev. 22:255–288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu JN and Roberts CWM: ARID1A mutations in
cancer: Another epigenetic tumor suppressor? Cancer Discov.
3:35–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maistro S, Teixeira N, Encinas G, Katayama
ML, Niewiadonski VD, Cabral LG, Ribeiro RM, Junior Gaburo N, de
Gouvêa AC, Carraro DM, et al: Germline mutations in BRCA1 and BRCA2
in epithelial ovarian cancer patients in Brazil. BMC Cancer.
16:9342016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hashimoto T, Yanaihara N, Okamoto A,
Nikaido T, Saito M, Takakura S, Yasuda M, Sasaki H, Ochiai K and
Tanaka T: Cyclin D1 predicts the prognosis of advanced serous
ovarian cancer. Exp Ther Med. 2:213–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chao WR, Lee MY, Lin WL, Chen CK, Lin JC,
Koo CL, Sheu GT and Han CP: HER2 amplification and overexpression
are significantly correlated in mucinous epithelial ovarian cancer.
Hum Pathol. 45:810–816. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bai H, Li H, Li W, Gui T, Yang J, Cao D
and Shen K: The PI3K/AKT/mTOR pathway is a potential predictor of
distinct invasive and migratory capacities in human ovarian cancer
cell lines. Oncotarget. 6:25520–25532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burkhalter RJ, Symowicz J, Hudson LG,
Gottardi CJ and Stack MS: Integrin regulation of beta-catenin
signaling in ovarian carcinoma. J Biol Chem. 286:23467–23475. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takayama Y, Kamimura Y, Okawa M, Muramatsu
S, Sugino A and Araki H: GINS, a novel multiprotein complex
required for chromosomal DNA replication in budding yeast. Genes
Dev. 17:1153–1165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang YP, Wang G, Bermudez V, Hurwitz J
and Chen XS: Crystal structure of the GINS complex and functional
insights into its role in DNA replication. Proc Natl Acad Sci USA.
104:12685–12690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
MacNeill SA: Structure and function of the
GINS complex, a key component of the eukaryotic replisome. Biochem
J. 425:489–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang YH, Galal WC, Farina A, Tappin I and
Hurwitz J: Properties of the human Cdc45/Mcm2-7/GINS helicase
complex and its action with DNA polymerase epsilon in rolling
circle DNA synthesis. Proc Natl Acad Sci USA. 109:6042–6047. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tumini E, Plevani P, Muzi-Falconi M and
Marini F: Physical and functional crosstalk between Fanconi anemia
core components and the GINS replication complex. DNA Repair
(Amst). 10:149–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barkley LR, Song I, Zou Y and Vaziri C:
Reduced expression of GINS complex members induces hallmarks of
pre-malignancy in primary untransformed human cells. Cell Cycle.
8:1577–1588. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thomassen M, Tan Q and Kruse TA: Gene
expression meta-analysis identifies chromosomal regions and
candidate genes involved in breast cancer metastasis. Breast Cancer
Res Treat. 113:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rantala JK, Edgren H and Lehtinen L:
Integrative functional genomics analysis of sustained polyploidy
phenotypes in breast cancer cells identifies an oncogenic profile
for GINS2. Neoplasia. 12:877–888. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng M, Zhou Y, Yang X, Tang J, Wei D,
Zhang Y, Jiang JL, Chen ZN and Zhu P: High GINS2 transcript level
predicts poor prognosis and correlates with high histological grade
and endocrine therapy resistance through mammary cancer stem cells
in breast cancer patients. Breast Cancer Res Treat. 148:423–436.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng L, Song Z, Chen D, Linghu R, Wang Y,
Zhang X, Kou X, Yang J and Jiao S: GINS2 regulates matrix
metallopeptidase 9 expression and cancer stem cell property in
human triple negative breast cancer. Biomed Pharmacother.
84:1568–1574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu M, Pan H, Zhang F, Zhang Y, Zhang Y,
Xia H, Zhu J, Fu W and Zhang X: Identification of TNM
stage-specific genes in lung adenocarcinoma by genome-wide
expression profiling. Oncol Lett. 6:763–768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao Y, Wang S, Liu B and Zhong L: Roles of
GINS2 in K562 human chronic myelogenous leukemia and NB4 acute
promyelocytic leukemia cells. Int J Mol Med. 31:1402–1410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Zhong L, Liu BZ, Gao YJ, Gao YM
and Hu XX: Effect of GINS2 on proliferation and apoptosis in
leukemic cell line. Int J Med Sci. 10:1795–1804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta (T))method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bertoli C, Skotheim JM and de Bruin RA:
Control of cell cycle transcription during G1 and S phases. Nat Rev
Mol Cell Biol. 14:518–528. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fisher RP: CDKs and cyclins in
transition(s). Curr Opin Genet Dev. 7:32–38. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yabuuchi H, Yamada Y, Uchida T,
Sunathvanichkul T, Nakagawa T and Masukata H: Ordered assembly of
Sld3, GINS and Cdc45 is distinctly regulated by DDK and CDK for
activation of replication origins. EMBO J. 25:4663–4674. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi JM, Lim HS, Kim JJ, Song OK and Cho
Y: Crystal structure of the human GINS complex. Genes Dev.
21:1316–1321. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cohen SM, Chastain PD II, Cordeiro-Stone M
and Kaufman DG: DNA replication and the GINS complex: Localization
on extended chromatin fibers. Epigenetics Chromatin. 2:62009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tessema M, Lehmann U and Kreipe H: Cell
cycle and no end. Virchows Arch. 444:313–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
